Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.
about
Conjugate vaccines for preventing Haemophilus influenzae type B infectionsConjugate vaccines for preventing Haemophilus influenzae type B infectionsWorldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugatesMucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescentsSerological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.Primary care provision of specialist services.Telemedicine: 'communication' by any other name?Keeping the meningococcus out of the media.Impact of the Haemophilus influenzae type b vaccination program on HIB meningitis in Brazil.The UK Hib vaccine experienceImmunogenicity of routine vaccination against diphtheria, tetanus, and Haemophilus influenzae type b in Asian infants born in the United Kingdom.Two or three primary dose regime for Haemophilus influenzae type b conjugate vaccine: meta-analysis of randomized controlled trialsNaturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in MaliVaccines based on the cell surface carbohydrates of pathogenic bacteria.Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.Population-based surveillance of Hib invasive infections in children in British Columbia Alberta and Ontario - 1995 to 1997.Prevention of Haemophilus influenzae type b disease: past success and future challenges.Epidemiology of invasive Haemophilus influenzae infections in England and Wales in the pre-vaccination era (1990-2).Prevention of pertussis across the age spectrum through the use of the combination vaccines PENTACEL and ADACEL.Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infantsCombination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates.New vaccines for the prevention of pneumococcal infections.Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trialsPreventing invasive salmonellosis in children through vaccination.Multiple concurrent childhood immunization.Secondary prevention of meningococcal disease. Penicillin is not recommended in British guidelines.Haemophilus influenza type b vaccine in Israel: experience in a paediatric ambulatory clinic.Measuring the impact of conjugate vaccines on invasive Haemophilus influenzae type b infection in Western Australia.Pneumococcal and Haemophilus influenzae meningitis in a children's hospital in Ethiopia: serotypes and susceptibility patterns.Meningitis in Hong Kong children, with special reference to the infrequency of haemophilus and meningococcal infection.Acute epiglottitis despite vaccination with haemophilus influenzae type B vaccine.Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants.Conjugate vaccines.Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations i
P2860
Q24240780-CEA7108B-7343-40DA-A7C2-7D99EB274B35Q24245094-4EF395EB-8EC6-456A-859B-C1A78EA7A537Q24514532-A5CB3FE7-F015-4E86-A03F-66E25301978FQ34004276-C20CC81A-55D0-45DA-8543-85A8552B9D0AQ34006352-043DD5A3-57DD-4F09-A1D1-249ADC16EA0DQ34214286-292A2F87-5220-4E8C-9F8E-10998DEC86EFQ34214294-5B012333-1E19-4BE4-ACD0-B0780D3D99D9Q34214301-DCB0954F-B267-43A0-BECF-70BF7F6BE371Q34638091-55BD179F-4503-42CB-ADA0-8DC17BD43424Q34649094-3B1E0225-AE90-40B3-98CE-5EF030081F16Q35283739-39084729-56BA-436C-8A44-811EDAE1A136Q35528932-973CC6FF-7E25-48D2-A88D-96C48D27096EQ36005810-CABC13D3-6348-443C-BE39-91F3A739002AQ36128243-C46BADA5-D10D-4B95-A9F9-AAD13A79785BQ36154043-303482A3-3644-4EB3-A0FF-0CE4E8C49DF3Q36170176-A989EB06-2BC4-4A00-81EA-55E09E2DBCF4Q36350560-4A829304-EB19-4046-B8AB-478221B55DA3Q36504293-0529784D-9B24-4F21-8FE5-BA13CD410BC2Q36541965-25FF2ACA-B6B5-4FBC-B4BA-7BB744F8A8E8Q36598037-E73D11E2-5FBF-49C7-8F7A-4C32ACF69771Q37077660-C5FEB135-5B94-42FE-8CA6-B3BF9E326C0DQ37091903-F57DA8B5-BF67-4750-81A5-1B619F0A115FQ38009929-62CD6106-8365-4BAF-9C48-FA7C2D25CFD6Q40107571-381C561F-2F50-4CDA-8AD5-49EB4E7E27EFQ42547603-0BBE5CC8-CA51-4DEA-A9DA-E9A553B74F59Q43188353-FFFEC385-A678-419C-9E23-6B482A85E7C8Q43209579-4676D6EA-5B2C-4006-9428-7F2C443BEE76Q43519397-AEC10871-D38D-418D-9AA7-6D381B1E5C50Q43632796-197DE24C-F233-42E1-8AD6-2669FC9F771AQ50625373-9415C152-8011-42FC-B17C-93564EC8F73AQ51427765-65BF2F7E-8AD0-4C84-B4C0-CB9EF41AB77AQ54047987-7FD82BC3-75C4-4B8F-8458-1C8E635803EBQ55033615-270547C5-D7C5-4A1E-9652-7CBC8EB3FE6BQ58476748-AA8C1380-203E-4988-8919-D6D6606A8BBF
P2860
Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.
@en
Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.
@nl
type
label
Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.
@en
Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.
@nl
prefLabel
Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.
@en
Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.
@nl
P2093
P1433
P1476
Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.
@en
P2093
E A Haworth
J A Macfarlane
J S Roberts
L Carpenter
R T Mayon-White
S Shribman
P304
P356
10.1016/S0140-6736(94)91400-1
P407
P577
1994-08-01T00:00:00Z